Navigation Links
Trana Discovery and Southern Research Institute Announce the First RNA-RNA High Throughput Drug Screening Assay Platform for HIV Antivirals
Date:9/17/2007

Collaboration validates unique HIV assay system that identifies potential

tRNA inhibitors

CARY, N.C. and BIRMINGHAM, Ala., Sept. 17 /PRNewswire-USNewswire/ -- Trana Discovery, a drug discovery company, today announced the development of a high throughput screening (HTS) assay for the identification of new compounds for the treatment of HIV. The HTS assay was developed in collaboration with Southern Research Institute, a research organization that conducts basic and applied preclinical drug research. This new assay gives pharmaceutical companies the ability to rapidly and efficiently screen vast libraries of compounds in order to identify those that interrupt the lifecycle of HIV through a novel mechanism of action -- the inhibition of transfer RNA (tRNA). This technology has the potential to discover new classes of medicines for the treatment of HIV that may overcome resistance mechanisms associated with current therapies.

To date in the U.S., about 30 drugs -- as single agents or as combination products -- for the treatment of HIV infections have been introduced by more than ten different companies. But collectively, these agents represent only five different classes working at just four different sites of action in the HIV replicative cycle. And despite the enhanced potency of the more recently introduced products, resistance continues to be a major challenge for managing patients with HIV.

There remains an unexploited target for antiretroviral drugs -- the disruption of human transfer RNA (tRNA) use by the virus during HIV replication. But until recently, several barriers, including the stability of the RNA-RNA binding during experimentation, had prevented exploration of tRNA as a drug target. Working in collaboration with Southern Research, Trana Discovery refined their technology to overcome those barriers in a HTS format, thus opening the way to discovery and development of HIV drugs that work by means of
'/>"/>

SOURCE Southern Research Institute
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Bentley Reports Positive Results with Nasulin Intranasal Insulin Spray at the American Diabetes Association Meeting
2. Trial Results with Intranasal Fentanyl Hold Promise for Treatment of Breakthrough Pain in Cancer
3. Roxro Pharma’s Novel Intranasal Pain Reliever Effective, Well Tolerated in Phase 3 Study
4. Javelin Pharmaceuticals Phase II Rylomine (Intranasal Morphine) Data Published in Pain Medicine
5. Daytrana (methylphenidate transdermal system) Provides Significant Effectiveness in ADHD Symptom Relief in Both Boys and Girls
6. 12-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA (methylphenidate transdermal system)
7. Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme
8. Discoverys KL-4 Surfactant Technology Demonstrates Novel Anti-Inflammatory Properties
9. Discovery Labs Presents Surfaxin and Aerosurf Data At the Pediatric Academic Societies Annual Meeting
10. Major Discovery Raises Prospect of Better Patient Care By Improving Platelet Life Span
11. Southern Research Institute to Present at the 2007 American Association For Cancer Research Annual Meeting

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...ia/--ChindexInternational,Inc.,("Chindex")(Nasdaq:...rn,healthcareproductsandservicesinthePeople,sRepub...the21stAnnualPiperJaffray,"Unplugged"HealthCareCon...ceHotel. , Managementiscurrentlyscheduledtopr...ne-on-onemeetingsthroughouttheday.Awebcast,ofthepr...
(Date:11/24/2009)...FirstCall/--Vermillion,Inc.(VRML)(PinkSheets:VRMLQ...dDisclosureStatementtoday,November24,2009,withtheU....AhearingtoconsiderapprovaloftheDisclosureStatemen...ingontheconfirmationofthePlanscheduledforJanuary7,...sinfull.ThePlanisexpected,ifapproved,toallowholder...
(Date:11/24/2009)...re-FirstCall/--ThoratecCorporation(Nasdaq: THOR ),...porttherapiestosave,supportandrestorefailinghearts...PiperJaffrayHealthCareConferenceonTuesday,December...effinancialofficer,willprovideanupdateonthecompany...PacificStandardTime). ,, Thepresentationwillbea...
Breaking Medicine Technology:Chindex International to Present at Piper Jaffray Health Care Conference 2Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Brown 26amp 3B Toland Supports Fight Against Hepatitis B 60447 1Brown 26amp 3B Toland Supports Fight Against Hepatitis B 60447 2NAMI Applauds Initial Review of The Affordable Health Care of America Act and Health Care Reform 60444 1NAMI Applauds Initial Review of The Affordable Health Care of America Act and Health Care Reform 60444 2NAMI Applauds Initial Review of The Affordable Health Care of America Act and Health Care Reform 60444 3Metropolitan Chicago Breast Cancer Task Force Announced Members of Chicago Breast Cancer Quality Consortium 60440 1Metropolitan Chicago Breast Cancer Task Force Announced Members of Chicago Breast Cancer Quality Consortium 60440 2Metropolitan Chicago Breast Cancer Task Force Announced Members of Chicago Breast Cancer Quality Consortium 60440 3Metropolitan Chicago Breast Cancer Task Force Announced Members of Chicago Breast Cancer Quality Consortium 60440 4Metropolitan Chicago Breast Cancer Task Force Announced Members of Chicago Breast Cancer Quality Consortium 60440 5
... Myeloma Workshop held in,Kos, Greece demonstrates...th bortezomib, dexamethasone and lenalidomide plus...ry multiple,myeloma, and as a single agent in pati...lobulinemia, NEW YORK, June 29, 2007 /PRNewswire-F...announced that 4 posters were,presented at the 11t...
... vaccine has shown 90%,efficacy for prevention of ...d with the human papillomavirus (HPV) types target...published early Online,and in the upcoming issue o... or more,cases of cervical cancer worldwide, but t...ntribute to cervical cancer. , Professor Jorma Paa...
Other Medicine Technology:Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 2Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 3Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 4Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 5Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 6Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 7Vaccine Can Prevent Cervical Cancer and Precancerous Lesions 2
(Date:11/26/2009)... , Benton Communications ...siness growth system for retailers struggling to m... (PRWEB) November 26, 2009 -- Flu fears is the t...les to the emergency room, according to Dr. David ...ewly released business growth system – The ...
(Date:11/25/2009)... ,, TORONTOandCALGARY,Nov.25/PRNewswire/-Sen...esonanceImaging(MRI)coilsandsoftwareandCalgaryScie...ologies,haveintroducedawebversionofAegis(TM)Breast...iveinterfaceisthefirsttrulyzero-footprintWebclient...ntific,sPureWeb(TM)platformallowsforzero-footprint...
(Date:11/25/2009)... ,, SANFRANCISCO,Nov.25/PRNewswire/--TheBayA...sfirst Winter Spare the Air Alert fo...facturedfirelogsoranyothersolidfuel,bothindoorsand...unhealthyairqualitytomorrow,"saidJackBroadbent,exe...esidentstorespectthehealthoftheirneighborsandfello...
(Date:11/25/2009)... , Does stress increase blood pressure? This sim...h for many years. New Stress-related gene Modulat... increase blood pressure? This simple question ha...s. Now new research has for the first time establ...the blood pressure response to stress in mice as w...
(Date:11/25/2009)... Survivors often plagued by neurological symptoms...ealthDay News) -- Neurological side effects are am...ivors of testicular cancer who were treated with c.... , The study included 1,409 Norwegian men trea...and 1994 who took part in a follow-up survey condu...
Breaking Medicine News(10 mins):Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:New stress-related gene modulates high blood pressure in mice and men 2
...day,announced the first true single port laparosco...tem., At Baystate Medical Center, Springfield, MA...Surgery, performed a gallbladder removal procedure...eals. This provides unobstructed access to the cav...
...n and Adults With Dis...ream Corporation,today announced results of its 27...ser to benefit Easter Seals. Since the conclusion ...se dollars,were raised during the chain-wide ,Cone...
...y,(NYSE: LLY ) today announced that the European ...EO(R) (teriparatide [rDNA origin] injection) for t...ined, systemic,glucocorticoid therapy in women and... Human Use (CHMP) of the European,Medicines Evalua...
...ording Artist Chaka Khan, LOS ANGELES, April 3, 2...millionth visitor to BODY WORLDS today. This marks...eaking run for BODY WORLDS,at the California Scien...onsored by her foundation, were at the,exhibit whe...
...er the incidents , , THURSDAY, April 3 (He...tner violence suffer a wide range of physical and ...zation study that included 25,000 women in 11 coun...d Republic of Tanzania.,The study found that havin...
... to join Harvard University,s Ash Institute for De... the bi-annual conference,Frontiers of Innovation:...ridge March 31st through today. On Monday evening,... neglected,diseases and in disaster preparedness i...
Other Medicine News:Health News:SurgiQuest Announces First Procedure Using AirSeal(TM) Access System 2Health News:Friendly's Dishes Out $616,000 for Easter Seals 2Health News:FORSTEO(R) Receives Approval from the European Commission for the Treatment of Glucocorticoid-Induced Osteoporosis 2Health News:FORSTEO(R) Receives Approval from the European Commission for the Treatment of Glucocorticoid-Induced Osteoporosis 3Health News:FORSTEO(R) Receives Approval from the European Commission for the Treatment of Glucocorticoid-Induced Osteoporosis 4Health News:FORSTEO(R) Receives Approval from the European Commission for the Treatment of Glucocorticoid-Induced Osteoporosis 5Health News:California Science Center Welcomes 1-Millionth BODY WORLDS Visitor 2Health News:Male Partner Violence Hurts Women's Health Worldwide 2Health News:PAHEF Discusses Neglected Diseases and Disaster Preparedness with Innovative Leaders 2
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
Medicine Products: